EDIT (Editas Medicine) Cyclically Adjusted Book per Share: $5.66 (As of Mar. 2026)


EDIT Editas Medicine Inc EDIT
51 GF Score
Price $3.20
GF Value $1.92
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Editas Medicine Cyclically Adjusted Book per Share?

Editas Medicine EDIT +11.89% 51 Cyclically Adjusted Book per Share is $5.66 as of Mar. 2026. GuruFocus rates EDIT with a GF Score™ of 51/100 and a GF Value™ of $1.92 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Editas Medicine's adjusted book value per share for the three months ended in Mar. 2026 was $0.045. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Editas Medicine's average Cyclically Adjusted Book Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-06-29), Editas Medicine's current stock price is $3.20. Editas Medicine's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $5.66. Editas Medicine's Cyclically Adjusted PB Ratio of today is 0.57.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Editas Medicine was 0.98. The lowest was 0.18. And the median was 0.43.


Editas Medicine  (NAS:EDIT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Editas Medicine's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.20/5.66
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Editas Medicine was 0.98. The lowest was 0.18. And the median was 0.43.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Editas Medicine Cyclically Adjusted Book per Share Related Terms


Editas Medicine Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Editas Medicine's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Editas Medicine Cyclically Adjusted Book per Share Chart

Editas Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 5.90 5.75

Editas Medicine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.85 5.76 5.68 5.75 5.66

EDIT vs SGMT, AUTL, FBRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Editas Medicine's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Editas Medicine Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Editas Medicine's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Editas Medicine's Cyclically Adjusted PB Ratio falls into.


EDIT
51GF Score
Editas Medicine Inc EDIT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Editas Medicine Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Editas Medicine's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.045/330.2130*330.2130
=0.045

Current CPI (Mar. 2026) = 330.2130.

Editas Medicine Quarterly Data

Book Value per Share CPI Adj_Book
201606 5.296 241.018 7.256
201609 4.779 241.428 6.536
201612 3.758 241.432 5.140
201703 5.071 243.801 6.868
201706 4.522 244.955 6.096
201709 4.249 246.819 5.685
201712 4.675 246.524 6.262
201803 5.299 249.554 7.012
201806 4.885 251.989 6.401
201809 4.725 252.439 6.181
201812 4.843 251.233 6.365
201903 4.439 254.202 5.766
201906 3.921 256.143 5.055
201909 4.111 256.759 5.287
201912 4.828 256.974 6.204
202003 4.280 258.115 5.476
202006 6.872 257.797 8.802
202009 7.094 260.280 9.000
202012 6.291 260.474 7.975
202103 9.456 264.877 11.788
202106 8.999 271.696 10.937
202109 8.589 274.310 10.339
202112 8.090 278.802 9.582
202203 7.474 287.504 8.584
202206 6.773 296.311 7.548
202209 6.032 296.808 6.711
202212 5.239 296.797 5.829
202303 4.601 301.836 5.034
202306 4.900 305.109 5.303
202309 4.414 307.789 4.736
202312 4.269 306.746 4.596
202403 3.580 312.332 3.785
202406 2.815 314.175 2.959
202409 2.128 315.301 2.229
202412 1.623 315.605 1.698
202503 0.746 319.799 0.770
202506 0.220 322.561 0.225
202509 0.144 324.800 0.146
202512 0.279 324.054 0.284
202603 0.045 330.213 0.045

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $5.66 mean?
Editas Medicine (EDIT) has a Cyclically Adjusted Book per Share of $5.66 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Editas Medicine and its competitors.
Is Editas Medicine's Cyclically Adjusted Book per Share too high?
Editas Medicine's current Cyclically Adjusted Book per Share is $5.66. Overall, Editas Medicine has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Editas Medicine's Cyclically Adjusted Book per Share compare to SGMT and AUTL?
Editas Medicine's Cyclically Adjusted Book per Share of $5.66 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Editas Medicine and its competitors. Editas Medicine's current Cyclically Adjusted Book per Share is $5.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Editas Medicine stock overvalued right now?
Based on GuruFocus' analysis, Editas Medicine (EDIT) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.92, compared to a current price of $3.20 — trading 66.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is $5.66. Editas Medicine's overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Editas Medicine (EDIT), the current Cyclically Adjusted Book per Share is $5.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Editas Medicine (EDIT) Overvalued in 2026?

Based on GuruFocus' analysis, Editas Medicine stock appears to be overvalued. The current stock price of $3.20 is trading 66.7% above its estimated GF Value™ of $1.92. GuruFocus considers Editas Medicine to be Significantly Overvalued.

Key valuation signals for EDIT:

  • Cyclically Adjusted Book per Share: $5.66
  • GF Value™: $1.92 vs. price of $3.20 (66.7% above fair value)
  • GF Score™: 51/100 with 8 warning signs

No single metric tells the full story. See the EDIT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Editas Medicine Business Description

Other Exchanges 0IFK:UK8EM:Germany
Address 11 Hurley Street, Cambridge, MA, USA, 02141
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
51GF Score

Get the complete analysis for EDIT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.20
Price
$1.92
GF Value